| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| INTRACOASTAL CAPITAL, LLC | 10% | $702,858 | 505,653 | Mitchell P. Kopin | 19 May 2025 |
As of 30 Sep 2025, 14 institutional investors reported holding 226,399 shares of Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM). This represents 4.5% of the company’s total 5,061,592 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 226,399 | $337,332 | +$143,732 | $1.49 | 14 |
| 2025 Q2 | 129,986 | $187,178 | +$49,049 | $1.44 | 12 |
| 2025 Q1 | 79,429 | $151,708 | +$100,024 | $1.91 | 11 |
| 2024 Q4 | 20,583 | $61,749 | -$45,450 | $3.00 | 12 |
| 2024 Q3 | 34,994 | $111,279 | +$111,279 | $3.00 | 10 |